# FDA Inspection 1223133 - Bloodworks - November 08, 2023

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/ae6291cf-e873-4241-96d2-3d3991840bbb
Source feed: FDA_Inspections

> FDA Inspection 1223133 for Bloodworks on November 08, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223133
- Company Name: Bloodworks
- Inspection Date: 2023-11-08
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1089146 - 2019-05-10](https://www.keypedia.com/records/fda_inspections/bloodworks/7ba6cb88-cf8d-4185-81aa-79ea72a3101b)
- [FDA Inspection 1019353 - 2017-07-17](https://www.keypedia.com/records/fda_inspections/bloodworks/117ced71-30bf-42b4-8707-e4bf215254fa)
- [FDA Inspection 884146 - 2014-06-23](https://www.keypedia.com/records/fda_inspections/bloodworks/543f605f-5f64-4694-ae1a-3f16412cb850)
- [FDA Inspection 796827 - 2012-08-20](https://www.keypedia.com/records/fda_inspections/bloodworks/d0e838b2-7875-4d20-9b76-c5ca4cb74adc)
- [FDA Inspection 718978 - 2011-04-05](https://www.keypedia.com/records/fda_inspections/bloodworks/ea4f415d-a126-40d9-a63b-6e5b557a25f4)

Company: https://www.keypedia.com/companies/bloodworks/f2ad1a4e-fc84-4177-9ed6-fd42a6088ea6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d